September 4, 2018
Macrolide Pharmaceuticals Expands Leadership and Strengthens Expertise in Drug Development, Clinical Strategy, Finance and Business Development Full Press Release Here
April 2, 2018
Macrolide Pharmaceuticals Appoints New President and CEO, Raises $20 Million in Investor Financing Full Press Release Here
March 26, 2018
Macrolide Pharmaceuticals Announces Up to $6.8 Million from CARB-X to Develop Macrolide Antibiotics with Gram-Negative Activity Full Press Release Here
March 15, 2018
Macrolide Pharmaceuticals Presents New Data on Tool to Differentiate Macrolide Antibacterial Drug by Risk of Liver Toxicity Full Press Release Here
October 5, 2017
Macrolide Pharmaceuticals Appoints Two New Board Members. Full Press Release Here
October 24, 2016
Andrew Myers research is discussed in the Harvard Magazine article Super Drugs for Super Bugs.
June 9, 2016
Macrolide Pharmaceuticals was featured this month in Biocentury Innovations article “Building A Better Haystack”, by Selina Koch.
May 24, 2016
Macrolide Pharmaceuticals Scientific Founder Publishes New Findings in Nature About Groundbreaking Technology for Novel Macrolide Antibiotics.
This is a scary situation. People talk about going backward to a pre-antibiotic era where you could go in for knee replacement surgery and lose your leg, or even your life, to an infection.Andrew Myers
Partner with us
We are eager to collaborate with academic institutions and other companies who are interested in macrolide development, and anti-bacterials broadly.